Bioavailability and Metabolism of Bioactive Compounds from Foods

Nutrition in the Prevention and Treatment of Disease, Third Edition

Volumn , Issue , 2012, Pages 407-423

  Neilson, Andrew P ^a   Ferruzzi, Mario G ^b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84938894813     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-391884-0.00022-6     Document Type: Chapter

References (128)

1. L. Hooper, P.A. Kroon, E.B. Rimm, J.S. Cohn, I. Harvey, K.A. Le Cornu, et al. (2008) Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88 38-50.
2. E. Herrera, R. Jiménez, O.I. Aruoma, S. Hercberg, I. Sánchez-García and C. Fraga (2009) Aspects of antioxidant foods and supplements in health and disease. Nutr. Rev. 67 S140-S144.
3. S. Prasad, K. Phromnoi, V.R. Yadav, M.M. Chaturvedi and B.B. Aggarwal (2010) Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med. 76 1044-1063.
4. A. Kale, S. Gawande and S. Kotwal (2008) Cancer phytotherapeutics: role for flavonoids at the cellular level. Phytother. Res. 22 567-577.
5. G. Davì, F. Santilli and C. Patrono (2010) Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc. Ther. 28 216-226.
6. M.G. Traber, B. Frei and J.S. Beckman (2008) Vitamin E revisited: do new data validate benefits for chronic disease prevention? Curr. Opin. Lipidol. 19 30-38.
7. J.A. Vita (2005) Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am. J. Clin. Nutr. 81 292S-297S.
8. D. Grassi, G. Desideri, G. Croce, S. Tiberti, A. Aggio and C. Ferri (2009) Flavonoids, vascular function and cardiovascular protection. Curr. Pharm. Design 15 1072-1084.
9. S.C. Thomasset, D.P. Berry, G. Garcea, T. Marczylo, W.P. Steward and A.J. Gescher (2007) Dietary polyphenolic phytochemicals—Promising cancer chemopreventive agents in humans? A review of their clinical properties. Int. J. Cancer 120 451-458.
10. A.V. Rao (2007) Carotenoids and human health. Pharmacol. Res. 55 207-216.
11. G. Riccioni (2009) Carotenoids and cardiovascular disease. Curr. Atheroscler. Rep 11 434-439.
12. C.L. Rock (2009) Carotenoids and cancer. G. Britton, H. Pfander, S. Liaaen-Jensen (Eds) Carotenoids Vol. 5 Basel: Birkhauser 269-286.
13. F. Galli and A. Azzi (2010) Present trends in vitamin E research. Biofactors 36 33-42.
14. J.M. Tucker and D.M. Townsend (2005) Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed. Pharmacother. 59 380-387.
15. R. Thangapazham, A. Sharma and R. Maheshwari (2006) Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 8 E443-E449.
16. P. Anand, C. Sundaram, S. Jhurani, A.B. Kunnumakkara and B.B. Aggarwal (2008) Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett. 267 133-164.
17. H. Hatcher, R. Planalp, J. Cho, F. Torti and S. Torti (2008) Curcumin: from ancient medicine to current clinical trials. Cell. Mol. Life Sci. 65 1631-1652.
18. C. Manach, A. Scalbert, C. Morand, C. Remesy and L. Jimenez (2004) Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79 727-747.
19. G.R. Beecher (2003) Overview of dietary flavonoids: Nomenclature, occurrence and intake. J. Nutr. 133 3248S-3254S.
20. A. Scalbert and G. Williamson (2000) Dietary intake and bioavailability of polyphenols. J. Nutr. 130 2073S-2085S.
21. L. Bravo (1998) Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 56 317-333.
22. K.E. Heim, A.R. Tagliaferro and D.J. Bobilya (2002) Flavonoid antioxidants: Chemistry, metabolism and structure–activity relationships. J. Nutr. Biochem. 13 572-584.
23. T. Iwashina (2000) The structure and distribution of the flavonoids in plants. J. Plant Res 113 287-299.
24. P.G. Pietta (2000) Flavonoids as antioxidants. J. Nat. Prod. 63 1035-1042.
25. L.H. Yao, Y.M. Jiang, J. Shi, F.A. Tomas-Barberan, N. Datta, R. Singanusong, et al. (2004) Flavonoids in food and their health benefits. Plant Foods Hum. Nutr. 59 113-122.
26. A.P. Neilson, A.S. Hopf, B.R. Cooper, M.A. Pereira, J.A. Bomser and M.G. Ferruzzi (2007) Catechin degradation with concurrent formation of homo- and heterocatechin dimers during in vitro digestion. J. Agric. Food Chem. 55 8941-8949.
27. A.P. Neilson, J.C. George, E.M. Janle, R.D. Mattes, R. Rudolph, N.V. Matusheski, et al. (2009) Influence of chocolate matrix composition on cocoa flavan-3-ol bioaccessibility in vitro and bioavailability in humans. J. Agric. Food Chem. 57 9418-9426.
28. A.P. Neilson, T.N. Sapper, E.M. Janle, R. Rudolph, N.V. Matusheski and M.G. Ferruzzi (2010) Chocolate matrix factors modulate the pharmacokinetic behavior of cocoa flavan-3-ol phase II metabolites following oral consumption by Sprague−Dawley rats. J. Agric. Food Chem. 58 6685-6691.
29. V. Crespy, C. Morand, C. Besson, N. Cotelle, H. Vezin, C. Demigne, et al. (2003) The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. Am. J. Physiol. Gastrointest. Liver Physiol. 284 G980-G988.
30. J.D. Lambert, S.M. Sang and C.S. Yang (2007) Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol. Pharm. 4 819-825.
31. J.B. Vaidyanathan and T. Walle (2003) Cellular uptake and efflux of the tea flavonoid (–)-epicatechin-3-gallate in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Therap 307 745-752.
32. M. Silberberg, C. Morand, C. Manach, A. Scalbert and C. Remesy (2005) Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism. Life Sci. 77 3156-3167.
33. W.Y. Feng (2006) Metabolism of green tea catechins: an overview. Curr. Drug Metab. 7 755-809.
34. M. Takano, R. Yumoto and T. Murakami (2006) Expression and function of efflux drug transporters in the intestine. Pharmacol. Ther. 109 137-161.
35. G. Williamson, A.J. Day, G.W. Plumb and D. Couteau (2000) Human metabolic pathways of dietary flavonoids and cinnamates. Biochem. Soc. Trans. 28 16-22.
36. R. Hackman, J. Polagruto, Q. Zhu, B. Sun, H. Fujii and C. Keen (2008) Flavanols: Digestion, absorption and bioactivity. Phytochem. Rev 7 195-208.
37. M.K. Piskula and J. Terao (1998) Accumulation of (–)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J. Nutr 128 1172-1178.
38. L.M.S. Chan, S. Lowes and B.H. Hirst (2004) The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 21 25-51.
39. C. Hu and D.D. Kitts (2001) Evaluation of antioxidant activity of epigallocatechin gallate in biphasic model systems in vitro. Mol. Cell. Biochem. 218 147-155.
40. J.B. Vaidyanathan and T. Walle (2001) Transport and metabolism of the tea flavonoid (–)-epicatechin by the human intestinal cell line Caco-2. Pharm. Res 18 1420-1425.
41. T. Kohri, N. Matsumoto, M. Yamakawa, M. Suzuki, F. Nanjo, Y. Hara, et al. (2001) Metabolic fate of (−)-[4-3H]epigallocatechin gallate in rats after oral administration. J. Agric. Food Chem. 49 4102-4112.
42. B.T. Zhu, U.K. Patel, M.X. Cai, A.J. Lee and A.H. Conney (2001) Rapid conversion of tea catechins to monomethylated products by rat liver cytosolic catechol-O-methyltransferase. Xenobiotica 31 879-890.
43. S.L. Abrahamse, W.J. Kloots and J.M.M. van Amelsvoort (2005) Absorption, distribution, and secretion of epicatechin and quercetin in the rat. Nutr. Res. 25 305-317.
44. J.D. Lambert, M.J. Lee, H. Lu, X.F. Meng, J. Ju, J. Hong, et al. (2003) Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J. Nutr. 133 4172-4177.
45. B. Yang, K. Arai and F. Kusu (2000) Determination of catechins in human urine subsequent to tea ingestion by high-performance liquid chromatography with electrochemical detection. Anal. Biochem 283 77-82.
46. T. Kohri, M. Suzuki and F. Nanjo (2003) Identification of metabolites of (–)-epicatechin gallate and their metabolic fate in the rat. J. Agric. Food Chem. 51 5561-5566.
47. C.S. Yang, L.S. Chen, M.J. Lee, D. Balentine, M.C. Kuo and S.P. Schantz (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev 7 351-354.
48. M. Harada, Y. Kan, H. Naoki, Y. Fukui, N. Kageyama, M. Nakai, et al. (1999) Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (–)-epicatechin. Biosci. Biotechnol. Biochem. 63 973-977.
49. C. Manach, G. Williamson, C. Morand, A. Scalbert and C. Remesy (2005) Bioavailability and bioefficacy of polyphenols in humans: I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81 230S-242S.
50. V. Mai and J.G. Morris (2004) Colonic bacterial flora: changing understandings in the molecular age. J. Nutr. 134 459-464.
51. S.H. Duncan, P. Louis and H.J. Flint (2007) Cultivable bacterial diversity from the human colon. Lett. Appl. Microbiol. 44 343-350.
52. A.M. O’Hara and F. Shanahan (2006) The gut flora as a forgotten organ. EMBO Rep 7 688-693.
53. M.B. Roberfroid, F. Bornet, C. Bouley and J.H. Cummings (1995) Colonic microflora: Nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr. Rev. 53 127-130.
54. F. Guarner and J.-R. Malagelada (2003) Gut flora in health and disease. Lancet 361 512-519.
55. J.L. Donovan, C. Manach, L. Rios, C. Morand, A. Scalbert and C. Remesy (2002) Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extract or the procyanidin dimer B-3. Br. J. Nutr. 87 299-306.
56. J.L. Donovan, S. Kasim-Karakas, J.B. German and A.L. Waterhouse (2002) Urinary excretion of catechin metabolites by human subjects after red wine consumption. Br. J. Nutr. 87 31-37.
57. M.J. Lee, P. Maliakal, L.S. Chen, X.F. Meng, F.Y. Bondoc, S. Prabhu, et al. (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (–)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev 11 1025-1032.
58. S.M. Henning, Y.T. Niu, N.H. Lee, G.D. Thames, R.R. Minutti, H.J. Wang, et al. (2004) Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am. J. Clin. Nutr. 80 1558-1564.
59. C. Auger, W. Mullen, Y. Hara and A. Crozier (2008) Bioavailability of poluphenon E flavan-3-ols in humans with an ileostomy. J. Nutr. 138 1535-1542.
60. S. Baba, N. Osakabe, M. Natsume and J. Terao (2002) Absorption and urinary excretion of procyanidin B2 epicatechin-(4 beta-8)-epicatechin in rats. Free Radic. Biol. Med. 33 142-148.
61. C. Tsang, C. Auger, W. Mullen, A. Bornet, J.M. Rouanet, A. Crozier, et al. (2005) The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Br. J. Nutr. 94 170-181.
62. M.M. Appeldoorn, J.P. Vincken, H. Gruppen and P.C.H. Hollman (2009) Procyanidin dimers A1, A2, and B2 are absorbed without conjugation or methylation from the small intestine of rats. J. Nutr. 139 1469-1473.
63. T. Shoji, S. Masumoto, N. Moriichi, H. Akiyama, T. Kanda, Y. Ohtake, et al. (2006) Apple procyanidin oligomers absorption in rats after oral administration: Analysis of procyanidins in plasma using the Porter method and high-performance liquid chromatography/tandem mass spectrometry. J. Agric. Food Chem 54 884-892.
64. R.R. Holt, S.A. Lazarus, M.C. Sullards, Q.Y. Zhu, D.D. Schramm, J.F. Hammerstone, et al. (2002) Procyanidin dimer B2 epicatechin-(4 beta-8)-epicatechin in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr. 76 798-804.
65. T. Kohri, M. Suzuki and F. Nanjo (2003) Identification of metabolites of (–)-epicatechin gallate and their metabolic fate in the rat. J. Agric. Food Chem. 51 5561-5566.
66. T. Kohri, F. Nanjo, M. Suziki, R. Seto, N. Matsumoto, M. Yamakawa, et al. (2001) Synthesis of (–)-4-H-3 epigallocatechin gallate and its metabolic fate in rats after intravenous administration. J. Agric. Food Chem. 49 1042-1048.
67. U. Justesen, E. Arrigoni, B.R. Larsen and R. Amado (2000) Degradation of flavonoid glycosides and aglycones during in vitro fermentation with human faecal flora. Lebensmittel-Wissenschaft Technol 33 424-430.
68. A.L. Simons, M. Renouf, S. Hendrich and P.A. Murphy (2005) Human gut microbial degradation of flavonoids: Structure−function relationships. J. Agric. Food Chem. 53 4258-4263.
69. N.P. Das and L.A. Griffith (1968) Studies on flavonoid metabolism: Metabolism of (+)-catechin in guinea pig. Biochem. J. 110 449.
70. N.P. Das and L.A. Griffith (1969) Studies on flavonoid metabolism: Metabolism of (+)-14C catechin in rat and guinea pig. Biochem. J. 115 831.
71. J. Winter, L.H. Moore, V.R. Dowell and V.D. Bokkenheuser (1989) C-ring cleavage of flavonoids by human intestinal bacteria. Appl. Environ. Microbiol. 55 1203-1208.
72. L. Bravo, R. Abia, M.A. Eastwood and F. Sauracalixto (1994) Degradation of polyphenols (catechin and tannic-acid) in the rat intestinal tract: effect on colonic fermentation and fecal output. Br. J. Nutr. 71 933-946.
73. X. Tzounis, J. Vulevic, G.G.C. Kuhnle, T. George, J. Leonczak, G.R. Gibson, et al. (2008) Flavanol monomer-induced changes to the human faecal microflora. Br. J. Nutr. 99(782–792),
74. H.C. Lee, A.M. Jenner, C.S. Low and Y.K. Lee (2006) Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res. Microbiol. 157 876-884.
75. M.P. Gonthier, V. Cheynier, J.L. Donovan, C. Manach, C. Morand, I. Mila, et al. (2003) Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J. Nutr. 133 461-467.
76. Y.-T. Lin, S.-L. Hsiu, Y.-C. Hou, H.-Y. Chen and P.-D.L. Chao (2003) Degradation of flavonoid aglycones by rabbit, rat and human fecal flora. Biol. Pharm. Bull. 26 747-751.
77. L.Y. Rios, M.-P. Gonthier, C. Remesy, I. Mila, C. Lapierre, S.A. Lazarus, et al. (2003) Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am. J. Clin. Nutr. 77 912-918.
78. K. Gao, A. Xu, C. Krul, K. Venema, Y. Liu, Y. Niu, et al. (2006) Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity. J. Nutr. 136 52-57.
79. R. Abia and S.C. Fry (2001) Degradation and metabolism of C-14-labelled proanthocyanidins from carob (Ceratonia siliqua) pods in the gastrointestinal tract of the rat. J. Sci. Food Agric 81 1156-1165.
80. S. Veeriah, T. Hofmann, M. Glei, H. Dietrich, F. Will, P. Schreier, et al. (2007) Apple polyphenols and products formed in the gut differently inhibit survival of human cell lines derived from colon adenoma (LT97) and carcinoma (HT29). J. Agric. Food Chem. 55 2892-2900.
81. M. Urpi-Sarda, M. Monagas, N. Khan, R.M. Lamuela-Raventos, C. Santos-Buelga, E. Sacanella, et al. (2009) Epicatechin, procyanidins, and phenolic microbial metabolites after cocoa intake in humans and rats. Anal. Bioanal. Chem. 394 1545-1556.
82. M.P. Gonthier, J.L. Donovan, O. Texier, C. Felgines, C. Remesy and A. Scalbert (2003) Metabolism of dietary procyanidins in rats. Free Radic. Biol. Med. 35 837-844.
83. A.M. Aura, I. Mattila, T. Seppanen-Laakso, J. Miettinen, K.M. Oksman-Caldentey and M. Oresic (2008) Microbial metabolism of catechin stereoisomers by human faecal microbiota: comparison of targeted analysis and a non-targeted metabolomics method. Phytochem. Lett 1 18-22.
84. S. Deprez, C. Brezillon, S. Rabot, C. Philippe, I. Mila, C. Lapierre, et al. (2000) Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J. Nutr. 130 2733-2738.
85. K. Kahle, W. Huemmer, M. Kempf, W. Scheppach, T. Erk and E. Richling (2007) Polyphenols are intensively metabolized in the human gastrointestinal tract after apple juice consumption. J. Agric. Food Chem. 55 10605-10614.
86. S. Stoupi, G. Williamson, J.W. Drynan, D. Barron and M.N. Clifford (2010) Procyanidin B2 catabolism by human fecal microflora: partial characterization of “dimeric” intermediates. Arch. Biochem. Biophys. 501 73-78.
87. S. Stoupi, G. Williamson, J.W. Drynan, D. Barron and M.N. Clifford (2009) A comparison of the in vitro biotransformation of (–)-epicatechin and procyanidin B2 by human faecal microbiota. Mol. Nutr. Food Res. 54 747-759.
88. G. van’t Slot and H.-U. Humpf (2009) Degradation and metabolism of catechin, epigallocatechin-3-gallate (EGCG), and related compounds by the intestinal microbiota in the pig cecum model. J. Agric. Food Chem 57 8041-8048.
89. M. Sharma, L. Li, J. Celver, C. Killian, A. Kovoor and N.P. Seeram (2009) Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling. J. Agric. Food Chem. 58 3965-3969.
90. S.G. Kasimsetty, D. Bialonska, M.K. Reddy, G. Ma, S.I. Khan and D. Ferreira (2010) Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J. Agric. Food Chem. 58 2180-2187.
91. A. Gonzalez-Sarrias, M. Larrosa, F.A. Tomas-Barberan, P. Dolara and J.C. Espin (2010) NF-kB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br. J. Nutr. 104 503-512.
92. D. Bialonska, S.G. Kasimsetty, S.I. Khan and D. Ferreira (2009) Urolithins, intestinal microbial metabolites of pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay. J. Agric. Food Chem. 57 10181-10186.
93. M. Larrosa, A. González-Sarrías, M.J. Yáñez-Gascón, M.V. Selma, M. Azorín-Ortuño, S. Toti, et al. (2010) Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J. Nutr. Biochem. 21 717-725.
94. S. Lu and L. Li (2008) Carotenoid metabolism: Biosynthesis, regulation, and beyond. J. Integrative Plant Biol. 50 778-785.
95. J.J.M. Castenmiller and C.E. West (1998) Bioavailability and bioconversion of carotenoids. Annu. Rev. Nutr. 18 19-38.
96. D. DellaPenna and B.J. Pogson (2006) Vitamin synthesis in plants: Tocopherols and carotenoids. Annu. Rev. Plant Biol. 57 711-738.
97. C.K. Sen, S. Khanna and S. Roy (2006) Tocotrienols: Vitamin E beyond tocopherols. Life Sci. 78 2088-2098.
98. M.L. Colombo (2010) An update on vitamin E, tocopherol and tocotrienol: Perspectives. Molecules 15 2103-2113.
99. C. Schneider (2005) Chemistry and biology of vitamin E. Mol. Nutr. Food Res. 49 7-30.
100. E. Fernandez-Garcia, I. Carvajal-Lerida, M. Jaren-Galan, J. Garrido-Fernandez, A. Perez-Galvez and D. Hornero-Mendez (2012) Carotenoids bioavailability from foods: from plant pigments to efficient biological activities. Food Res. Int. 46 438-450.
101. S. Goltz and M.G. Ferruzzi (2012) Factors affecting carotenoid bioavailability: Dietary fat and fiber. S. Tanumihardjo (Eds) Carotenoids and Human Health New York: Spinger
102. E. Kotake-Nara and A. Nagao (2011) Absorption and metabolism of xanthophylls. Marine Drugs 9 1024-1037.
103. E.H. Harrison (2012) Mechanisms involved in the intestinal absorption of dietary vitamin A and provitamin A carotenoids. Biochim. Biophys. Acta 1821 70-77.
104. M.J. Brown, M.G. Ferruzzi, M.L. Nguyen, D.A. Cooper, A.L. Eldridge, S.J. Schwartz, et al. (2004) Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. Am. J. Clin. Nutr. 80 396-403.
105. E. Reboul, M. Richelle, E.Ø. Perrot, C. Desmoulins-Malezet, V. Pirisi and P. Borel (2006) Bioaccessibility of carotenoids and vitamin E from their main dietary sources. J. Agric. Food Chem. 54 8749-8755.
106. T. Huo, M.G. Ferruzzi, S.J. Schwartz and M.L. Failla (2007) Impact of fatty acyl composition and quantity of triglycerides on bioaccessibility of dietary carotenoids. J. Agric. Food Chem. 55 8950-8957.
107. E.G. Kean, B.R. Hamaker and M.G. Ferruzzi (2008) Carotenoid bioaccessibility from whole grain and degermed maize meal products. J. Agric. Food Chem. 56 9918-9926.
108. A.R. Kohut, M.L. Failla, B.A. Watkins and M.G. Ferruzzi (2007) The impact of lipid quantity and type on carotenoid bioaccessibility from vegetables. FASEB J. 21 A350.
109. M.G. Ferruzzi, J.L. Lumpkin, S.J. Schwartz and M. Failla (2006) Digestive stability, micellarization, and uptake of beta-carotene isomers by Caco-2 human intestinal cells. J. Agric. Food Chem. 54 2780-2785.
110. T.Y. Huo, M.G. Ferruzzi, M.A. Belury, S.J. Schwartz and M.L. Failla (2007) Impact of amount and triglyceride (TG) structure on micellarization of dietary carotenoids during simulated digestion. FASEB J. 21 A730-A731.
111. K. Anwar, J. Iqbal and M.M. Hussain (2007) Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption. J. Lipid Res. 48 2028-2038.
112. J. Iqbal and M.M. Hussain (2009) Intestinal lipid absorption. Am. J. Physiol. Endocrinol. Metab. 296 E1183-E1194.
113. A. Rigotti (2007) Absorption, transport, and tissue delivery of vitamin E. Mol. Aspects Med. 28 423-436.
114. L. Brisson, S. Castan, H. Fontbonne, C. Nicoletti, A. Puigserver and E.H. Ajandouz (2008) Alpha-tocopheryl acetate is absorbed and hydrolyzed by Caco-2 cells: comparative studies with alpha-tocopherol. Chem. Phys. Lipids 154 33-37.
115. R. Wajda, J. Zirkel and T. Schaffer (2007) Increase of bioavailability of coenzyme Q(10) and vitamin E. J. Medicinal Food 10 731-734.
116. Y. O’Callaghan and N. O’Brien (2010) Bioaccessibility, cellular uptake and transepithelial transport of alpha-tocopherol and retinol from a range of supplemented foodstuffs assessed using the caco-2 cell model. Int. J. Food Sci. Technol. 45 1436-1442.
117. E. Reboul and P. Borel (2011) Proteins involved in uptake, intracellular transport and basolateral secretion of fat-soluble vitamins and carotenoids by mammalian enterocytes. Prog. Lipid Res. 50 388-402.
118. P. Anand, A.B. Kunnumakkara, R.A. Newman and B.B. Aggarwal (2007) Bioavailability of curcumin: problems and promises. Mol. Pharm. 4 807-818.
119. A. Shehzad, F. Wahid and Y.S. Lee (2010) Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch. Pharmazie 343 489-499.
120. T. Hamaguchi, K. Ono and M. Yamada (2010) Review: Curcumin and Alzheimer’s disease. CNS Neurosci. Ther. 16 285-297.
121. S. Bisht and A. Maitra (2009) Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. Curr. Drug Discov. Technol. 6 192-199.
122. C.R. Ireson, D.J.L. Jones, S. Orr, M.W.H. Coughtrie, D.J. Boocock, M.L. Williams, et al. (2002) Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev. 11 105-111.
123. R.A. Sharma, W.P. Steward and A.J. Gescher (2007) Pharmacokinetics and pharmacodynamics of curcumin. Adv. Exp. Med. Biol. 595 453-470.
124. E. Burgos-Morón, J.M. Calderón-Montaño, J. Salvador, A. Robles and M. López-Lázaro (2010) The dark side of curcumin. Int. J. Cancer 126 1771-1775.
125. B.T. Kurien and R.H. Scofield (2009) Oral administration of heat-solubilized curcumin for potentially increasing curcumin bioavailability in experimental animals. Int. J. Cancer 125 1992-1993.
126. J. Shaikh, D.D. Ankola, V. Beniwal, D. Singh and M.N.V.R. Kumar (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci. 37 223-230.
127. M.J. Kang, J.Y. Cho, B.H. Shim, D.K. Kim and J. Lee (2009) Bioavailability enhancing activities of natural compounds from medicinal plants. J. Med. Plants Res. 3 1204-1211.
128. A. Khajuria, N. Thusu and U. Zutshi (2002) Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine 9 224-230.